COMMUNIQUÉS West-GlobeNewswire

Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
07/05/2024
ANX007 demonstrated significant, broad-based protection from vision loss in foveal and non-foveal patients, and in low light settings ANX007 protected key retinal structures important for vision: significant reduction [...]
AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient
07/05/2024
PRESS RELEASE A NEW PUBLICATION IN THE MEDICAL JOURNAL MUSCLE & NERVE VALIDATES THE USE OF THE RATE OF DECLINE OF ALSFRS-R SCORE (ΔFS) FOR THE DESIGN OF CLINICAL STUDIES AND THE TREATMENT CHOICE FOR AMYOTROPHIC [...]
AB Science:
07/05/2024
COMMUNIQUE DE PRESSE UNE NOUVELLE PUBLICATION DANS LA REVUE MÉDICALE MUSCLE & NERVE VALIDE L’UTILISATION DU DECLIN DU SCORE ALSFRS-R (ΔFS) POUR LE DESIGN DES ETUDES CLINIQUES ET LE CHOIX DE TRAITEMENT DES PATIENTS [...]
Philips shareholders approve all proposals at the AGM 2024
07/05/2024
May 7, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2024, including: The re- [...]
NTG Nordic Transport Group publishes interim report for Q1 2024
07/05/2024
Company announcement no. 5 – 24 7 May 2024 NTG Nordic Transport Group publishes interim report for Q1 2024 The interim report for Q1 2024 is enclosed. In connection with publication of the results for Q1 2024, a [...]
New Discovery Identifies “Don’t Eat Me” Protein that Allows Lyme Bacteria to Evade Body’s Immune Response
07/05/2024
Stanford University/MIT/UCSF study funded by Bay Area Lyme Foundation offers new direction for tick-borne disease research, paving the way for potential new discoveries PALO ALTO, Calif., May 07, 2024 (GLOBE NEWSWIRE [...]
Ibogaine By David Dardashti Launches New Software for Treatment Dose
07/05/2024
Optimizing Precision and Efficiency with Innovative Software MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce the launch of their new treatment dose software, designed to optimize [...]
Syntekabio to Showcase Biologics Discovery Platform at PEGS Boston
07/05/2024
Company offering discovery services for neoantigens with Neo-ARS and for full antibodies with Ab-ARS NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug [...]
Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA
07/05/2024
The Company expands its range of CGMP services to include small-scale commercial APIs MILAN, Italy, May 07, 2024 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a global Contract Development and Manufacturing [...]
Teknova Launches Proprietary Build-Tek™ Solutions Custom Configurator and Latest AAV-Tek™ Product to Further Accelerate Novel Therapy Development
07/05/2024
First-of-its-kind custom configurator – available today – gives scientists access to high quality, customizable buffers in small volumes for use in early-stage experiments, all with exceptionally short turnaround times [...]
FibroBiologics to Present at the BIO International Convention 2024
07/05/2024
HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of [...]
Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock
07/05/2024
- Conversions Eliminate All Variable Priced Derivative Securities - Conversions Eliminate Any Market Overhang from Warrants - Series A Preferred and Warrant Conversions were Investor Initiated - Limited Number of [...]
Medigene to Present at Upcoming Conferences
07/05/2024
Planegg/Martinsried, May 7, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid [...]
Visory Health's New Prescription Habits Report Reveals Medication Affordability Challenges Among Millennials, the Sandwich Generation and Beyond
07/05/2024
As drug prices rise across America, millennials, the sandwich generation and older adults are turning to alternatives to afford prescriptions and other necessary bills ESTERO, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- [...]
Clinical Study Highlights Improvements to Gut Microbiome and Autism Spectrum Disorder Symptoms with Use of Custom Probiotics
07/05/2024
62% of Participants Reported Improvement in Overall Autism-related Symptoms and Gastrointestinal Discomfort SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Researchers with Sun Genomics and Arizona State University (ASU) [...]
HealthEquity Sets Date to Announce First Quarter Results
07/05/2024
Presentation at Conferences DRAPER, Utah, May 07, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today [...]
SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
07/05/2024
SANTA CLARA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced the [...]
ALX Oncology Appoints Allison Dillon as Chief Business Officer
07/05/2024
SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune [...]
Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business
07/05/2024
SALT LAKE CITY, May 07, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the reorganization of its European operations to better align [...]

Pages